WallStreetZenWallStreetZen

NYSE: CTLT
Catalent Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CTLT

Based on 12 analysts offering 12 month price targets for Catalent Inc.
Min Forecast
$42.00+6.14%
Avg Forecast
$50.58+27.83%
Max Forecast
$62.00+56.68%

Should I buy or sell CTLT stock?

Based on 12 analysts offering ratings for Catalent Inc.
Buy
Strong Buy
4 analysts 33.33%
Buy
2 analysts 16.67%
Hold
5 analysts 41.67%
Sell
1 analysts 8.33%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CTLT stock forecasts and price targets.

CTLT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-16
lockedlocked$00.00+00.00%2023-11-16
lockedlocked$00.00+00.00%2023-11-16
lockedlocked$00.00+00.00%2023-09-29
lockedlocked$00.00+00.00%2023-09-05
Bank of America
Top 8%
93
SellMaintains$46.00+16.25%2023-08-31
Morgan Stanley
Bottom 4%
4
Strong BuyMaintains$55.00+38.99%2023-08-30
UBS
Bottom 10%
10
Strong BuyMaintains$58.00+46.58%2023-08-30
Deutsche Bank
Bottom 6%
6
HoldMaintains$45.00+13.72%2023-08-15
Stephens & Co.
Bottom 11%
11
Strong BuyReiterates$50.00+26.36%2023-06-21

1 of 2

Forecast return on equity

Is CTLT forecast to generate an efficient return?
Company
N/A
Industry
0.05%
Market
30.07%

Forecast return on assets

Is CTLT forecast to generate an efficient return on assets?
Company
N/A
Industry
0.03%

CTLT revenue forecast

What is CTLT's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$4.4B-2.53%
Avg 2 year Forecast
$4.7B+3.79%
Avg 3 year Forecast
$5.0B+11.52%
CTLT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CTLT earnings growth forecast

How is CTLT forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
278.17%
Industry
22.29%
Market
17.91%
CTLT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CTLT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CTLT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CTLT revenue growth forecast

How is CTLT forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
3.62%
Industry
6.39%
Market
7.54%
CTLT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CTLT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CTLT vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
CTLT$39.57$50.58+27.83%Buy
ELAN$12.02$12.38+2.95%Sell
ITCI$59.43$78.20+31.58%Strong Buy
LNTH$70.04$112.00+59.91%Strong Buy
PRGO$30.34$42.50+40.08%Strong Buy
View Top Pharmaceutical Stocks

Catalent Stock Forecast FAQ

Is Catalent Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NYSE: CTLT) stock is to Buy CTLT stock.

Out of 12 analysts, 4 (33.33%) are recommending CTLT as a Strong Buy, 2 (16.67%) are recommending CTLT as a Buy, 5 (41.67%) are recommending CTLT as a Hold, 1 (8.33%) are recommending CTLT as a Sell, and 0 (0%) are recommending CTLT as a Strong Sell.

If you're new to stock investing, here's how to buy Catalent stock.

What is CTLT's revenue growth forecast for 2024-2026?

(NYSE: CTLT) Catalent's forecast annual revenue growth rate of 3.62% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 6.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.54%.

Catalent's revenue in 2023 is $4,495,000,000.On average, 6 Wall Street analysts forecast CTLT's revenue for 2024 to be $789,807,633,300, with the lowest CTLT revenue forecast at $784,567,854,876, and the highest CTLT revenue forecast at $794,059,162,039. On average, 7 Wall Street analysts forecast CTLT's revenue for 2025 to be $841,029,865,516, with the lowest CTLT revenue forecast at $828,015,147,174, and the highest CTLT revenue forecast at $849,727,075,660.

In 2026, CTLT is forecast to generate $903,688,356,709 in revenue, with the lowest revenue forecast at $886,991,047,242 and the highest revenue forecast at $921,790,704,125.

What is CTLT's forecast return on assets (ROA) for 2024-2026?

(NYSE: CTLT) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.03%.

What is CTLT's Price Target?

According to 12 Wall Street analysts that have issued a 1 year CTLT price target, the average CTLT price target is $50.58, with the highest CTLT stock price forecast at $62.00 and the lowest CTLT stock price forecast at $42.00.

On average, Wall Street analysts predict that Catalent's share price could reach $50.58 by Nov 16, 2024. The average Catalent stock price prediction forecasts a potential upside of 27.83% from the current CTLT share price of $39.57.

What is CTLT's forecast return on equity (ROE) for 2024-2026?

(NYSE: CTLT) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.